HIGH-YIELD RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs mammalian cell lines for the generation of therapeutic antibodies. Chinese hamster ovary (CHO) cells developed as a leading platform due to their productivity in producing complex, humanized antibodies. High-yield growth of CHO cells is crucial for cost-effectiveness and involves meticulous optimization of va